Top compounds associated with response to TMA7


Feature Type Standardized
Nominal ANOVA
mRNA ML083 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.077 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.02
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.085 0.02
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.084 0.03
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.19 0.03
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA niclosamide CTRPv2 pan-cancer AAC 0.079 0.03
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV